BIO Stock Summary and Trading Ideas (Bio-Rad Laboratories Class A | NYSE:BIO)

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

What symbol and exchange does Bio-Rad Laboratories Class A shares trade?

Bio-Rad Laboratories Class A trades on the NYSE stock market under the symbol BIO.

What is Bio-Rad Laboratories Class A stock price doing today?

As of May 1, 2026, BIO stock price declined to $256.55 with 969,853 million shares trading.

What is Bio-Rad Laboratories Class A's Beta?

BIO has a beta of 0.75, meaning it tends to be less sensitive to market movements. BIO has a correlation of 0.08 to the broad based SPY ETF.

How much is Bio-Rad Laboratories Class A worth?

BIO has a market cap of $6.92 billion. This is considered a Mid Cap stock.

How much money does Bio-Rad Laboratories Class A make?

Last quarter Bio-Rad Laboratories Class A reported $592 million in Revenue and $1.89 earnings per share. This beat revenue expectation by $5 million and missed earnings estimates by -$.25.

What is the highest and lowest price Bio-Rad Laboratories Class A traded in the last 3 year period?

In the last 3 years, BIO traded as high as $473.50 and as low as $211.43.

What are the top ETFs holding Bio-Rad Laboratories Class A?

The top ETF exchange traded funds that BIO belongs to (by Net Assets): IJH, VTI, VB, VBR, VXF.

Is Bio-Rad Laboratories Class A (BIO) a good investment?

BIO has underperformed the market in the last year with a price return of +6.7% while the SPY ETF gained +30.4%. BIO has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -12.6% and -14.2%, respectively, while the SPY returned +4.4% and +1.5%, respectively.

What are the support and resistance levels for Bio-Rad Laboratories Class A (BIO)?

BIO support price is $273.69 and resistance is $286.55 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BIO shares will trade within this expected range on the day.